{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T16:19:44Z","timestamp":1781108384523,"version":"3.54.1"},"reference-count":36,"publisher":"Informa Healthcare","issue":"5","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Drug Safety"],"published-print":{"date-parts":[[2015,5,4]]},"DOI":"10.1517\/14740338.2015.1017468","type":"journal-article","created":{"date-parts":[[2015,3,3]],"date-time":"2015-03-03T10:07:45Z","timestamp":1425377265000},"page":"777-788","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":40,"title":["Safety and tolerability of 5-grass pollen tablet sublingual immunotherapy: pooled analysis and clinical review"],"prefix":"10.1517","volume":"14","author":[{"given":"Alain","family":"Didier","sequence":"first","affiliation":[{"name":"1Rangueil-Larrey Hospital, Respiratory Diseases Department, 24 Chemin de Pouvourville \u2013 TSA 30030, 31059 Toulouse Cedex 9, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Bons","sequence":"additional","affiliation":[{"name":"2Stallergenes, Corporate Pharmacovigilance Department, Antony, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3197","published-online":{"date-parts":[[2015,3,3]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.2500\/aap.2008.29.3179"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1097\/ACI.0b013e32834a9676"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1177\/1753465811431975"},{"key":"CIT0004","unstructured":"EFA Book on Respiratory Allergies. EValovirta. editor. 2011. Available from: http:\/\/www.theipcrg.org\/download\/attachments\/689587\/EFABookonRespiratoryAllergiesFINAL.pdf?version=1&modificationDate=1332965739000 [Last accessed 2 April 2014]"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2008.06.003"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.2500\/aap.2012.33.3535"},{"key":"CIT0007","unstructured":"WAO White Book on Allergy 2013 Update. RPawankar, STHolgate, GWCanonica, et al. editors. 2013. Available from: http:\/\/www.worldallergy.org\/UserFiles\/file\/WhiteBook2-2013-v8.pdf [Last accessed 23 February 2015]"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2007.01620.x"},{"key":"CIT0009","first-page":"1440","volume":"81","author":"Sur DK","year":"2010","journal-title":"Am Fam Physician"},{"issue":"1","key":"CIT0010","first-page":"CD001936","author":"Calderon MA","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1002\/lary.24295"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2011.02761.x"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1186\/1939-4551-7-6"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2013.02.013"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.3310\/hta17270"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1586\/1744666X.2014.957677"},{"key":"CIT0017","unstructured":"Summary of Product Characteristics: Oralair\u00ae 100 IR & 300 IR sublingual tablets. Stallerg\u00e8nes SA, 2013. Available from: http:\/\/www.stallergenes.co.uk\/fileadmin\/images\/corporate\/gallery\/Documents_pdf\/2010-10\u2013Oralair_fin_MRP_RCP.pdf [Last accessed 15 April 2014]"},{"key":"CIT0018","unstructured":"US Prescribing Information: Oralair\u00ae (Sweet vernal, Orchard, Perennial rye, Timothy, and Kentucky blue grass mixed pollens allergen extract) Tablet for sublingual use. Stallerg\u00e8nes SA, 2014. Available from: http:\/\/oralair.com\/docs\/ORALAIR%20Prescribing%20Information-Med%20Guide.pdf [Last accessed 11 May 2014]"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2012.08.032"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2007.07.046"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1111\/cea.12100"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2011.06.022"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2009.06.006"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2006.01203.x"},{"key":"CIT0025","unstructured":"Study NCT00803244. Safety and efficacy of Phase III study on 300 IR SLIT in patients suffering from grass pollen rhinoconjunctivitis (with or without asthma). Stallerg\u00e8nes SA, 2011. Available from: http:\/\/clinicaltrials.gov\/show\/NCT00803244 [Last accessed 20 April 2014]"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2008.10.009"},{"key":"CIT0027","volume-title":"Guidelines for preparing core clinical safety information on drugs","author":"Council for International Organizations of Medical Sciences (CIOMS) Working Group III","year":"1995"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.2165\/11591730-000000000-00000"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2014.01.004"},{"key":"CIT0030","first-page":"391","volume-title":"J Allergy Clin Immunol","volume":"117","author":"Sampson HA","year":"2006"},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.1111\/pai.12268"},{"key":"CIT0032","doi-asserted-by":"publisher","DOI":"10.1007\/s40267-40014-40131-40267"},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.1097\/ACI.0000000000000075"},{"key":"CIT0034","first-page":"253","volume":"19","author":"Madsen F","year":"2009","journal-title":"J Investig Allergol Clin Immunol"},{"key":"CIT0035","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2011.09.007"},{"key":"CIT0036","doi-asserted-by":"publisher","DOI":"10.1097\/ACI.0b013e3283588c8d"}],"updated-by":[{"DOI":"10.1517\/14740338.2015.1055674","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2015,6,18]],"date-time":"2015-06-18T00:00:00Z","timestamp":1434585600000}}],"container-title":["Expert Opinion on Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1517\/14740338.2015.1017468","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T18:10:07Z","timestamp":1598638207000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1517\/14740338.2015.1017468"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,3]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5,4]]}},"alternative-id":["10.1517\/14740338.2015.1017468"],"URL":"https:\/\/doi.org\/10.1517\/14740338.2015.1017468","relation":{"correction":[{"id-type":"doi","id":"10.1517\/14740338.2015.1055674","asserted-by":"object"}]},"ISSN":["1474-0338","1744-764X"],"issn-type":[{"value":"1474-0338","type":"print"},{"value":"1744-764X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,3]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2015-04-21","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}